Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2332128
Max Phase: Preclinical
Molecular Formula: C31H46O6
Molecular Weight: 514.70
Molecule Type: Small molecule
Associated Items:
ID: ALA2332128
Max Phase: Preclinical
Molecular Formula: C31H46O6
Molecular Weight: 514.70
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Rel-Carinatin D
Synonyms from Alternative Forms(1):
Canonical SMILES: C=C1C(=O)O[C@@H]2C[C@@H]3[C@]4(CC[C@]5(C)[C@@H]([C@H](C)CC(=O)CC(C)(C)O)CC[C@@]35C)C[C@]4(CCC(=O)OC)[C@H]12
Standard InChI: InChI=1S/C31H46O6/c1-18(14-20(32)16-27(3,4)35)21-8-10-29(6)23-15-22-25(19(2)26(34)37-22)31(11-9-24(33)36-7)17-30(23,31)13-12-28(21,29)5/h18,21-23,25,35H,2,8-17H2,1,3-7H3/t18-,21-,22-,23+,25-,28-,29+,30+,31-/m1/s1
Standard InChI Key: IAPFVMVXUKIQBQ-QQUVVESZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 514.70 | Molecular Weight (Monoisotopic): 514.3294 | AlogP: 5.41 | #Rotatable Bonds: 8 |
Polar Surface Area: 89.90 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.56 | CX LogD: 4.56 |
Aromatic Rings: 0 | Heavy Atoms: 37 | QED Weighted: 0.34 | Np Likeness Score: 3.17 |
1. Kongkum N, Tuchinda P, Pohmakotr M, Reutrakul V, Piyachaturawat P, Jariyawat S, Suksen K, Akkarawongsapat R, Kasisit J, Napaswad C.. (2013) Cytotoxic, antitopoisomerase IIα, and anti-HIV-1 activities of triterpenoids isolated from leaves and twigs of Gardenia carinata., 76 (4): [PMID:23550966] [10.1021/np3006887] |
Source(1):